世界中医药2023，Vol.18Issue(19)：2766-2771,6.DOI:10.3969/j.issn.1673-7202.2023.19.009
中医药治疗艾滋病随机对照试验评价指标的现状分析
Evaluation Index of Randomized Controlled Trials of AIDS Treated by Traditional Chinese Medicine
摘要
Abstract
Objective:To obtain the outcome indexes of randomized controlled trials of AIDS treated by traditional Chinese medi-cine(TCM)through the analysis of related literature,and to provide reference for selecting appropriate outcome indexes for TCM treatment of AIDS in future.Methods:Literature including randomized controlled trials of TCM diagnosis and treatment of AIDS was included by searching China National Knowledge Infrastructure(CNKI),Wanfang Data,VIP,China Biology Medicine disc(CBM),Chinese Science Citation Database(CSPD),Chinese Citation Database(CCD),PubMed,EMbase and Cochrane Library.Results:A total of 32 articles were selected,involving 7 642 patients and 42 outcome indexes for 155 times,which included TCM syndrome score,physical and chemical indexes,safety events,western medicine signs,quality of life,and long-term prognosis.And it was insufficient in terms of physical and chemical indexes(72,46.45％),safety incidents(43,27.74％),TCM syndrome score(12,7.74％),long-term prognosis and safety indexes.Conclusion:At present,there is large difference in the number of outcome indexes and limited types in the TCM treatment of AIDS,as well as large differences in measurement time points and TCM charac-teristic therapies,with low attention to long-term prognosis and quality of life,and lack of standards for composite indexes.This pa-per provides reference for selecting outcome indexes of clinical randomized controlled trials of TCM treatment of AIDS in future through the analysis of existing Chinese core literature.关键词
中医药/艾滋病/随机对照试验/文献研究/评价指标/结局分析/借鉴Key words
Traditional Chinese medicine/AIDS/Randomized controlled trials/Literature research/Evaluation indexes/Out-come indexes/Reference分类
中医学引用本文复制引用
钟鹏展,徐立然,郭家乐,黄铭燕,宋夕元..中医药治疗艾滋病随机对照试验评价指标的现状分析[J].世界中医药,2023,18(19):2766-2771,6.基金项目
国家自然科学基金项目(U1604287) （U1604287）
国家"十三五"科技重大专项(2017ZX10205502),河南省中医管理局中医临床研究基地专项(2017JDZX001) （2017ZX10205502）
河南省中医药科学研究专项(2021JDZY001) （2021JDZY001）
